Race-specific reference ranges of serum prostate-specific antigen levels in countries with a low incidence of prostate cancer

BJU International

Volumn 97, Issue 1, 2006, Pages 69-72

  Ku, Ja Hyeon ^a  

^a Seoul Veterans Hospital   (South Korea)

Author keywords

Asian; Diagnosis; Prostate carcinoma; Prostate specific antigen; Reference range

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CALCULATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; ETHNOLOGY; HUMAN; INCIDENCE; MASS SCREENING; PATHOLOGY; PHYSIOLOGY; POPULATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE; REVIEW; RISK ASSESSMENT; TRANSURETHRAL RESECTION; ADULT; AGED; ARTICLE; ASIA; BLOOD; MALE; MIDDLE AGED; PROSTATE TUMOR; REFERENCE VALUE;

ADULT; AGED; AGED, 80 AND OVER; ASIA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES;

EID: 33644787918     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05866.x     Document Type: Review

References (36)

1. Oesterling JE Jacobsen SJ Chute CG et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges JAMA 1993 270 860 4
2. Morgan TO Jacobsen SJ McCarthy WF Jacobson DJ McLeod DG Moul JW Age-specific reference ranges for prostate-specific antigen in black men N Engl J Med 1996 335 304 10
3. Oesterling JE Kumamoto Y Tsukamoto T et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men Br J Urol 1995 75 347 53
4. Imai K Ichinose Y Kubota Y et al. Clinical significance of prostate specific antigen for early stage prostate cancer detection Jpn J Clin Oncol 1994 24 160 5
5. Imai K Ichinose Y Kubota Y Yamanaka H Sato J Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer J Urol 1995 154 1085 9
6. Ito K Yamamoto T Kubota Y et al. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer Urology 2000 56 278 82
7. He D Wang M Chen X et al. Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population Urology 2004 63 722 6
8. Lin WY Gu CJ Kao CH Changlai SP Wang SJ Serum prostate-specific antigen in healthy Chinese men: establishment of age-specific reference ranges Neoplasma 1996 43 103 5
9. Kao CH Age-related free PSA, total PSA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males Anticancer Res 1997 17 1361 5
10. Wu TT Huang JK The clinical usefulness of prostate-specific antigen (PSA) level and age-specific PSA reference ranges for detecting prostate cancer in Chinese Urol Int 2004 72 208 11
11. Tay KP Chin CM Lim PH Chng HC Prostate screening - the Singapore experience Int J Urol 1996 3 102 7
12. Saw S Aw TC Age-related reference intervals for free and total prostate-specific antigen in a Singaporean population Pathology 2000 32 245 9
13. Lee SE Kwak C Park MS Lee CH Kang W Oh SJ Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population Urology 2000 56 1007 10
14. Ku JH Ahn JO Lee CH et al. Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity Urology 2002 60 475 9
15. Catalona WJ Prostate-specific antigen in black men N Engl J Med 1997 336 134 6
16. Egawa S Suyama K Ohori M et al. Early detection of prostate cancer. Results of a prostate specific antigen-based detection program in Japan Cancer 1995 76 463 72
17. Kobayashi T Nishizawa K Ogura K Mitsumori K Ide Y Detection of prostate cancer in men with prostate-specific antigen levels of 2.0-4.0 ng/mL equivalent to that in men with 4.1-10.0 ng/mL in a Japanese population Urology 2004 63 727 31
18. Zagars GK Pollack A Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome Urology 1995 45 476 83
19. Scaletscky R Koch MO Eckstein CW Bicknell SL Gray GF Smith JA Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen J Urol 1994 152 129 31
20. Schmid HP McNeal JE Stamey TA Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume Cancer 1993 71 2031 40
21. Shibata A Whittemore AS Imai K et al. Serum levels of prostate-specific antigen among Japanese-American and native Japanese men J Natl Cancer Inst 1997 89 1716 20
22. Hsing AW Tsao L Devesa SS International trends and patterns of prostate cancer incidence and mortality Int J Cancer 2000 85 60 7
23. Shimizu H Ross RK Bernstein L Yatani R Henderson BE Mack TM Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County Br J Cancer 1991 63 963 6
24. Cook LS Goldoft M Schwartz SM Weiss NS Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants J Urol 1999 161 152 5
25. Muir CS Nectoux J Staszewski J The epidemiology of prostatic cancer. Geographical distribution and time-trends Acta Oncol 1991 30 133 40
26. Van Cangh PJ De Nayer P Sauvage P et al. Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer Prostate Suppl 1996 7 30 4
27. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1992-93 estimates based on data from seven population-based cancer registries Jpn J Clin Oncol 1998 28 641 7
28. Brawer MK Chetner MP Beatie J Buchner DM Vessella RL Lange PH Screening for prostatic carcinoma with prostate specific antigen J Urol 1992 147 841 5
29. Labrie F Dupont A Suburu R et al. Serum prostate specific antigen as pre-screening test for prostate cancer J Urol 1992 147 846 52
30. Catalona WJ Smith DS Ratliff TL et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 1991 324 1156 61
31. Yu HJ Chie WC Hsieh CH Tsai CC Lai MK Clinical efficacy of prostate-specific antigen testing in patients with prostate disease J Formos Med Assoc 1996 95 782 8
32. Yu HJ Lai MK The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer Urology 1998 51 Suppl. 5A 125 30
33. Im YJ Kim JW Hong SJ Chung BH Proper cut-off value of free to total PSA ratio for detection of prostate cancer in Korean men Yonsei Med J 2004 45 873 8
34. Yatani R Shiraishi T Nakakuki K et al. Trends in frequency of latent prostate carcinoma in Japan from 1965-79 to 1982-1986 J Natl Cancer Inst 1988 80 683 7
35. Sakr WA Haas GP Cassin BF Pontes JE Crissman JD The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients J Urol 1993 150 379 85
36. Egawa S Matsumoto K Suyama K Iwamura M Kuwao S Baba S Observations of prostate specific antigen doubling time in Japanese patients with nonmetastatic prostate carcinoma Cancer 1999 86 463 9